We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$433B
AUM Growth
+$39.3B
Cap. Flow
+$6.99B
Cap. Flow %
1.61%
Top 10 Hldgs %
19.86%
Holding
3,573
New
35
Increased
2,384
Reduced
635
Closed
102

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.16B
2
HSY icon
Hershey
HSY
+$663M
3
LMT icon
Lockheed Martin
LMT
+$622M
4
MO icon
Altria Group
MO
+$525M
5
PFE icon
Pfizer
PFE
+$499M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.76B
2
MRK icon
Merck
MRK
+$2.35B
3
ADP icon
Automatic Data Processing
ADP
+$1.57B
4
BX icon
Blackstone
BX
+$1.38B
5
ITW icon
Illinois Tool Works
ITW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 12.71%
3 Healthcare 11.72%
4 Consumer Discretionary 10.09%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZOM
3351
DELISTED
Zomedica Corp.
ZOM
$60.2K ﹤0.01%
412,334
LFT
3352
Lument Finance Trust
LFT
$34.6M
$59.8K ﹤0.01%
24,035
STXS icon
3353
Stereotaxis
STXS
$126M
$59.2K ﹤0.01%
22,696
RLMD icon
3354
Relmada Therapeutics
RLMD
$557M
$58.1K ﹤0.01%
12,505
RSSS icon
3355
Research Solutions
RSSS
$73.6M
$57.1K ﹤0.01%
18,069
ABAT icon
3356
American Battery Technology Co
ABAT
$285M
$56.9K ﹤0.01%
32,528
+1
+0% +$3
PXLW icon
3357
Pixelworks
PXLW
$38.2M
$56.7K ﹤0.01%
1,830
VANI icon
3358
Vivani Medical
VANI
$110M
$55.5K ﹤0.01%
30,017
LFCR icon
3359
Lifecore Biomedical
LFCR
$166M
$55.4K ﹤0.01%
10,427
AREC icon
3360
American Resources Corp
AREC
$191M
$54.7K ﹤0.01%
38,760
MAPS
3361
DELISTED
WM TECHNOLOGY INC A
MAPS
$54.4K ﹤0.01%
40,927
CTMX icon
3362
CytomX Therapeutics
CTMX
$675M
$54.1K ﹤0.01%
24,817
CHMI
3363
Cherry Hill Mortgage Investment Corp
CHMI
$83M
$53.1K ﹤0.01%
15,001
ARC
3364
DELISTED
ARC Document Solutions, Inc.
ARC
$52.7K ﹤0.01%
19,042
CIA icon
3365
Citizens
CIA
$239M
$52.7K ﹤0.01%
24,606
ATYR
3366
aTyr Pharma
ATYR
$47.6M
$52K ﹤0.01%
26,689
PFIE
3367
DELISTED
Profire Energy, Inc
PFIE
$51.2K ﹤0.01%
27,669
GROV icon
3368
Grove Collaborative
GROV
$46.2M
$51K ﹤0.01%
30,520
REKR icon
3369
Rekor Systems
REKR
$85.8M
$50.4K ﹤0.01%
22,007
ETON icon
3370
Eton Pharmaceutcials
ETON
$1.27B
$49.6K ﹤0.01%
13,239
GNSS icon
3371
Genasys
GNSS
$76.1M
$49.6K ﹤0.01%
20,918
SPRO icon
3372
Spero Therapeutics
SPRO
$67.7M
$49.1K ﹤0.01%
28,565
WRAP icon
3373
Wrap Technologies
WRAP
$103M
$48.6K ﹤0.01%
21,515
QBTS icon
3374
D-Wave Quantum Inc. Common Stock
QBTS
$6.7B
$47.6K ﹤0.01%
23,310
AUGX
3375
DELISTED
Augmedix, Inc. Common Stock
AUGX
$47.4K ﹤0.01%
11,589

Similar funds

Charles Schwab's Q1 2024 Portfolio in Review

As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
  • Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
  • Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
  • Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
  • Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.